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Abstract
A case of male, 34 years old with a diagnosis of immunodeficiency syndrome resulting from HIV infection with
suspected pneumonia in the differential diagnosis of pulmonary tuberculosis relapse, in the course of the disease,
patients experienced hypersensitivity reactions to some antibiotics and antituberculosis drugs. Hypersensitivity
reactions were exaggerated by immune response to an allergen in a normal immune system. In this case, we found
the drug hypersensitivity reactions in patients with immunodeficiency. Until now, the exact underlying mechanism is
not fully known but may be due to multifactorial and the dysregulation of the immune system due to HIV infection.
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Introduction
Acquired Immunodeficiency Syndrome (AIDS) is a collection of
symptoms caused by Human Immunodeficiency Virus (HIV)
infection, an RNA virus including Retrovirus from the lentivirus
family, which attacks the immune system [1,2].
The main target of HIV infection is the CD4+ lymphocytes (T
helper/Th) which play a central role in the immune system. In the early
course of the disease, the immune system can control the HIV
infection, but with the course of the disease, HIV will further cause a
decrease number of CD4+ lymphocytes, disruption of homeostasis and
function of other cells in the immune system. This situation will
further lead to various symptoms with a wide clinical spectrum as the
result of a disturbance in the function of cellular and humoral
immunity. These viruses cause disease through several mechanisms
including immune deficiency that causes opportunistic infections,
autoimmune reactions and hypersensitivity reactions as well as
tendency of malignancy [1,2].
Hypersensitivity reactions are excessive immune response to an
allergen in a normal immune system. Drug hypersensitivity is an
excessive immune response to the drug substance or its metabolites
through immunological reactions that occur during or after the use of
drugs in which this mechanism may be mediated by immunoglobulin
or T lymphocytes. Hypersensitivity reactions according to Gell and
Coombs are classified into four types: type I reaction is immediate
hypersensitivity played by IgE, the type II reaction is a cytotoxic
reaction played by IgM/IgG, type III reaction or immune complex
reaction played by IgM/IgG, and type IV reactions are delayed type
hypersensitivity that is not played by antibodies but by T lymphocytes
[3].
Drug hypersensitivity reaction in HIV infection often occurs. In
fact, it is reported to occur 100 times more frequently than non-HIV
patients. Drug hypersensitivity reactions in HIV-infected patients are
clinically similar to drug hypersensitivity reactions in non HIV-
infected [4]. Although drug hypersensitivity reactions in patients with
HIV infection often occurs but the case is very rarely reported.
We report one case, male 34 years with immunodeficiency
syndrome due to HIV infection in the course of his illness he
experienced a hypersensitivity reaction to some antibiotics and
antituberculosis drugs.
Case Report
A male patient, 34 years old, entered hospital with a chief complaint
of shortness of breath experienced since one week before
hospitalization. Shortness of breath was felt constantly, not influenced
by the activity and positional change. Since a week ago, patient
experienced productive cough, with white mucous, no blood, left chest
pain is felt especially when coughing. Fever experienced since one
week, especially at night, no chills, no seizures and no headache. No
nausea and vomiting, loss of appetite three days before entering the
hospital. Patients gained weight in the last six months but previously
experienced a weight loss of about 5-10 kg in five years. Normal
urination and defecation.
No history of asthma and food or medication allergies, no history of
recurrent diarrhea, no history of blood transfusion, there is a history of
smoking since high school and drug abuse, no history of free sex.
Other data regarding the history of previous illness was ever treated
with typhoid fever in 1998, 2001 and 2004. In 2004 history of Morbili,
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2005 hospitalized with heart valve disorder, and 2009 patients had
recurrent stomatitis accompanied by infection of left and dextra
inguinal. Patient was given Ciprofoxacin but allergic skin symptoms
appeared after a few minutes taking the drug. Since January 2010 he
was diagnosed with lung tuberculosis. Patient was given oral anti-
tuberculosis drugs, 4 Fixed Dose Combination (4FDC) four times a
day. Allergy symptoms such as skin rash appeared at the whole body
accompanied by itching and shortness of breath which occured after
approximately one week taking the 4FDC medication. FDC then
replaced with separate medicine (Rifampicin/INH/Pyrazinamide/
Ethambutol). About a week later the same allergy symptoms appeared,
and then the patient was declared allergic to Rifampicin and
Pyrazinamide.
The physical examination found, the impression was seriously ill,
well-nourished with body mass index (BMI) of 23.3 kg/m2, compos
mentis, blood pressure 120/80 mmHg, respiratory 30 times per minute
thoracoabdominal, 38, 20°C axillary temperature, pulse 92 times/
minute. Examination of the oral cavity found oral candidiasis.
Bronkovesikuler breath sounds on thoracic auscultation, additional
sound was rales at the apex of the left lung, no wheezing.
Based on the history and physical examination, working diagnosis
was suspected pneumonia with differential diagnosis pulmonary TB
relaps and suspected immunodeficiency syndrome. Initial therapy was
given high-protein, high-calorie diet, oxygen, isotonic infusion fluid
and paracetamol. Until the third day of treatment, patients often
experienced shortness of breath, fever (37.80°C to 39.50°C), coughing
with sputum. Oral candidiasis, bronkovesikuler respiratory sounds,
rales at the apex of the left lung. Laboratory results; leukocytes
9,800/uL, hemoglobin; 10.3 g/dl, the red blood cells: 5.42 x 106/uL,
hematocrit; 33.8%, platelets; 274,000 /uL, monocytes; 9%, segment;
82%, lymphocytes; 9% , eosinophil 8%, erythrocyte sedimentation rate;
74 mm 1st h and 92 mm at 2nd hour, renal function within normal
limits and chest X-ray impression: bilateral bronchopneumonia.
Additional therapy was given Ceftriaxone injection 1 g/12 h, skin test
before ceftriaxon injection found positive allergic reactions such as
erythema and edema locally. Ceftriaxone then replaced by 200 mg
Ofloxacin twice daily. Laboratory results of HIV rapid test is reactive
(positive), CD4 laboratory results; the absolute value was 18 cells/pl
(Normal range 410-1590 cells/pl) and the percentage was 2% (Normal
range 31-60), the T-helper lymphocytes count was very less. Patient
confirmed positive HIV. Added ARV therapy (Lamivudine,
Zidovudine and efavirenz) twice daily, Ceftazidine 1 g/12 h/IV, but the
results show positive skin test allergy (local erythema and edema).
Ceftazidine replaced with Cefotaxime 1 g twice daily intravenous.
Other drugs are co-trimoxazole, Bromhexine HCL and Fluconazole
(Table 1).
Time September 2009 January 2010 July 2010 July 2010
Drug name Ciprofloxacin Rifampicin
Pyrazinamide
Ceftriaxon Ceftazidine
Time of reaction after taking the
drug
A few minutes A week 5 minutes 5 minutes
Symptoms Red spots on the skin of the whole
body accompanied by intense
itching and nausea
Red spots on the skin the whole
body accompanied by intense
itching and shortness of breath
Red spots and edema when
skin tests
Red spots and edema when
skin tests
Table 1: Summary of drugs hypersensitivity reaction history.
On the 15th day of treatment, the patient was allowed to go home
and outpatient care. At that time the patient's condition is good, no
fever, no shortness of breath, a temperature of 36°C, respiratory 16
times per minute, no oral candidiasis, respiratory sound
bronchovesicular with rales at the apex of the left lung.
Discussion
We reported a case, male 34 years with immunodeficiency
syndrome resulting from HIV infection with suspected pneumonia,
pulmonary TB relapse, and in the course of his illness, patients
experienced hypersensitivity reactions to some antibiotics and
antituberculosis drugs. Further discussion on this case focused on the
drug hypersensitivity reactions in immunodeficiency due to HIV
infection.
Patient in this case did not have a history of allergic diseases or
allergies to drugs and food. A tendency to experience allergic reactions
begins to occur after the appearance of symptoms of
immunodeficiency disease. Reported that a hypersensitivity reaction to
trimethoprim-sulfametoksazole occurs 60% in HIV-positive patients
and only 5% in immunocompetent or immunodeficient not due to
HIV infection. Giving antituberculosis isoniazid (INH), pyrazinamide
(PZA) and rifampicin in HIV-infected patients will be at risk of drug
hypersensitivity 20 times more often than those who not HIV-infected
[5]. The drugs often reported allergic reactions in patients who are
HIV positive is trimethoprim-sulfamethoxazole, penicillin group,
antituberculosis, antiretroviral, non-steroidal anti-inflammatory drugs
(NSAIDs) and anticonvulsants [6]. The reason underlying the increase
in drug hypersensitivity reactions in people infected with HIV have
not clearly known, but the dysregulation of the immune system on T
and B lymphocytes is likely play a role and some multifactorial
including changes in drug metabolism, oxidative stress, cytokine
profile, hyperactivation of the immune system and genetic factors are
suspected play a role for this mechanism. HIV itself can be a dangerous
signal that tends to cause an immune response than the immune
tolerance [5,7].
The pathogenesis of hypersensitivity reactions in HIV infection is
not clearly known, considered through an allergic reaction (immune
mediated) or because of unknown causes toxic. However, this
hypersensitivity reaction cannot be put into one of the four types of
hypersensitivity reactions by Gell and Coombs classification. This is
indeed very contradictory that hypersensitivity reaction occurs in
people who 'energy' against some other stimulants [8].
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Some conditions are thought to play a role [1,9], disregulations on
the immune system: reaction to amoxicillin, trimethoprim-
sulfametokzasol and OAT medicine often occurs in low CD4 levels
(20-<200/uL). Histopathologic examination showed similar
abnormalities, independent to the drug precipitating, estimated as the
general nature pathogenesis [2]. Co-infection with other viruses: such
as Epstein-Barr virus (EBV), cytomegalovirus (CMV) and some other
respiratory viruses reported to be associated with the occurrence of
skin rash due to Ampicillin. Not found the incidence of skin rash when
the acute phase of infection by these viruses has passed [3]. The dose
and duration of using drug also play a role: It’s found that
hypersensitivity reaction often occur for the high-dose trimethoprim-
sulfametokzasol when compared with low doses as a prophylactic. The
longer the medicine consumed, the higher possibility of a
hypersensitivity reaction [4]. Other factors ecg immunoglobulins that
are specific to a particular drug and drug structure and its metabolism
in the body.
CD4+ lymphocytes is a central regulator of the immune system
that these cells have two types of T helper-1 (Th-1) and -2 (Th-2)
which are differentiated by cytokines released. Th-1 cells produce
interferon gamma (INF-ɣ) and interleukin (IL)-2 which is an
important mediator of the cellular immune response, while Th-2
produces IL-4, IL-5, IL-6 and IL-10 which is an important mediator for
the humoral immune respon that help B lymphocytes produce
antibodies [10]. HIV infection not only causes immunodeficiency, but
also lead to dysregulation of the immune system. It plays an important
role in the progression of the HIV disease [11]. Once infected by HIV,
changes in cytokine profiles appears as it found an increase in
production of IL-4 which is always accompanied by increased
production of IL-5 and decreased production of INF-ɣ [10]. Clerici et
al. reported that in the early phase of HIV infection, the cytokines
produced by Th-1 and Th-2 still in a normal balance, but later, the
cytokines produced by Th-2 (IL-4) increase while cytokine produced
by Th-1 (IL-2) decrease. It supports the shift from Th-1 to Th-2 in the
early phase of HIV infection [12]. Clinical findings that support an
increase in the production of Th-2 cytokine is the allergic
manifestation and increase levels of IgE in patients infected with HIV,
in which the increase serum levels of IgE significantly associated with a
reduction in CD4+ cells count (less than 200/mm2) [13-15]. In the
further clinical course, the progressive decline in the production of
IL-2 and IL-4 cytokines occur. In the humoral immune system, HIV
itself causes the stimulation of B lymphocytes polyclonally and
unspecificaly which cause a problem because of an unappropriate
immune response [12].
The results of in vitro studies demonstrate that HIV-infected cells
may be more susceptible to damage and cell death directly due to the
reaction of drug metabolites, further damage or cell death is then
interpreted as a "danger signal" and stimulate the T lymphocytes to
initiate a series of immune responses and the release of cytokines
which manifests as a drugs hypersensitivity reaction [16]. Glutathione
deficiency in HIV infection is considered as another mechanism that
may be the cause. Other studies demonstrate that HIV replication is
stimulated by Tat protein, which is the Tat protein expression
associated with increased oxidative stress, decreased glutathione
biosynthesis and cellular concentration. Glutathione seems to play a
role in protection of cells from a toxic metabolite substance [5,17].
Some types of viral infection is associated with the occurrence of
an allergic reaction to medicine. The virus include; human herpes virus
6 (HHV-6), Epstein-Barr virus (EBV) and paramixovirus. Co-infection
with some viruses common in HIV positive patients. Virus can interact
with the immune system through several points; during drug
metabolism, during the presentation of medicine/drug metabolites by
dendritic cells as antigen presenting cells (APC) to lymphocytes and
when cytokine and kemokin production [18-20].
In 1992, from Zimbabwe reported that the anti-tuberculosis drug
reactions more frequently in HIV-positive patients (98 of 363 patients)
than patients who were not infected with HIV (64 of 543). Most
frequent clinical manifestations of hypersensitivity reactions due to
OAT medicine in HIV-positive patients are skin hypersensitive (64%).
This reaction arises almost entirely within the first 8 weeks giving OAT
[21,22]. In this case, the patient has an allergy when taking
OAT 4FDC, reddish spots appeared at the entire body accompanied by
itching and shortness of breath that comes after a week of taking the
medication. After administration of antituberculosis medicine
separately, the patient then known allergic to Rifampicin and
Pyrazinamide. In the combination therapy, it is difficult to determine
which drug caused the reaction but Rifampicin is reported as the most
frequent cause of reaction [23]. These patients also have allergic
reactions to quinolones class. Anaphylactic reaction to ciprofloxacin
were reported more frequently found in HIV-positive patients and
often fatal [23,24].
Action taken in the event of drug hypersensitivity reactions in
patients with immunodeficiency is to stop or avoid medications shown
to cause hypersensitivity reactions and replace with other drugs with
the same therapeutic purposes. Desensitization or the role of using
corticosteroids as immunosuppresant is fully unknown. Treatment
aimed essentially for the underlying disease in which hypersensitivity
reactions will disappear along with the improvement of the patient's
immune system [2].
Summary
We reported a case, male 34 years with immunodeficiency
syndrome resulting from HIV infection with suspected pneumonia,
pulmonary TB relapse, and in the course of his illness, patients
experienced hypersensitivity reactions to some antibiotics and OAT.
Patient in this case did not have a history of allergic diseases or
allergies to drugs and food. A tendency to experience allergic reactions
to some medicines begin occurs after the appearance of
immunodeficiency disease symptoms. The clinical symptoms of allergy
reaction were reddish spots at entire body accompanied by itching and
shortness of breath.
Drugs hypersensitivity reactions are more common in HIV-infected
patients. Until now, the exact mechanism underlying this reaction is
not fully known but may be due to multifactorial and the dysregulation
of the immune system by HIV infection. However, at
immunodeficiency drugs hypersensitivity cannot be entered in the one
of four types of hypersensitivity reactions by Gell and Coombs
classification.
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